We are live on ! Find out more
BNTX icon

BioNTech

282 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 91 increasing their positions, 70 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 38

30% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 70

12% more funds holding

Funds holding: 252282 (+30)

8% more capital invested

Capital invested by funds: $4.01B → $4.34B (+$330M)

1.92% more ownership

Funds ownership: 15.42%17.33% (+1.9%)

5% more call options, than puts

Call options by funds: $234M | Put options by funds: $224M

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
282
Holders Change
+30
Holders Change %
+11.9%
% of All Funds
4.11%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
70
Increased
91
Reduced
70
Closed
38
Calls
$234M
Puts
$224M
Net Calls
+$10.8M
Net Calls Change
+$12.2M
Name Holding Trade Value Shares
Change
Change in
Stake
US Bancorp
76
US Bancorp
Minnesota
$3.02M +$2.33M +23,119 +421%
ERSOT
77
Employees Retirement System of Texas
Texas
$2.77M +$266K +2,638 +11%
DZ Bank
78
DZ Bank
Germany
$2.77M -$1.61M -16,000 -38%
Parallax Volatility Advisers
79
Parallax Volatility Advisers
California
$2.76M -$267K -2,652 -9%
PFU
80
Parus Finance (UK)
United Kingdom
$2.74M +$31.4K +312 +1%
CIS
81
Capital International Sarl
California
$2.51M +$145K +1,437 +6%
Barclays
82
Barclays
United Kingdom
$2.51M -$1.3M -12,933 -35%
LSA
83
Leonteq Securities AG
Switzerland
$2.5M -$1.05M -10,422 -31%
BCM
84
Bronte Capital Management
Australia
$2.47M -$13.6K -135 -0.6%
ACM
85
Advisors Capital Management
New Jersey
$2.4M -$512K -5,079 -18%
OAM
86
Oppenheimer Asset Management
New York
$2.38M +$2.28M +22,591 New
Mackenzie Financial
87
Mackenzie Financial
Ontario, Canada
$2.3M +$1.69M +16,743 +326%
CI
88
Capital International
California
$2.22M +$21.8K +216 +1%
VA
89
Vident Advisory
Georgia
$2.01M +$56.2K +558 +3%
GS
90
GTS Securities
New York
$1.94M -$1.2M -11,926 -39%
GC
91
Guggenheim Capital
Illinois
$1.92M -$86K -853 -4%
HighTower Advisors
92
HighTower Advisors
Illinois
$1.9M +$802K +7,957 +81%
CAPTRUST Financial Advisors
93
CAPTRUST Financial Advisors
North Carolina
$1.8M +$1.3M +12,907 +310%
GBWM
94
Granite Bay Wealth Management
New Hampshire
$1.79M -$258K -2,564 -13%
Fifth Third Bancorp
95
Fifth Third Bancorp
Ohio
$1.76M +$1.63M +16,224 +3,881%
Natixis Advisors
96
Natixis Advisors
Massachusetts
$1.66M +$1.59M +15,766 New
VOYA Investment Management
97
VOYA Investment Management
Georgia
$1.62M +$1.54M +15,305 New
Neuberger Berman Group
98
Neuberger Berman Group
New York
$1.56M +$1.49M +14,800 New
IFLIT
99
Investmentaktiengesellschaft Fuer Langfristige Investoren TGV
Germany
$1.53M +$302K +3,000 +26%
Mariner
100
Mariner
Kansas
$1.5M +$1.16M +11,553 +433%

BNTX Hedge Fund Activity: Q4 2023 in Review

282 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2023, worth a combined $4.34B — up 8.2% from $4.01B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new BNTX positions and 38 closed out — a net gain of 32 holders — while 91 added to existing stakes and 70 trimmed.

The largest buyer was Harding Loevner, opening a new position worth an estimated $397M. The largest seller was Artisan Partners, cutting an estimated $67.6M.

  • 282 institutional investors held BioNTech (BNTX) as of Q4 2023, up from 252 in Q3 2023.
  • Funds reported $4.34B of BioNTech stock for Q4 2023, up 8.2% quarter-over-quarter.
  • 70 funds opened new BioNTech positions in Q4 2023 and 38 closed out, a net change of +32 holders.
  • The largest BioNTech buyer in Q4 2023 was Harding Loevner, an estimated $397M added.
  • The largest BioNTech seller in Q4 2023 was Artisan Partners, an estimated $67.6M sold.

Based on aggregated 13F filings for Q4 2023.